These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38916462)

  • 1. [Myocardial viability: when and how to look for it, its prognostic impact and interaction with benefits of revascularization].
    Bolognese L; Reccia MR
    G Ital Cardiol (Rome); 2024 Jul; 25(7):475-482. PubMed ID: 38916462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial Viability Assessment Before Surgical Revascularization in Ischemic Cardiomyopathy: JACC Review Topic of the Week.
    Panza JA; Chrzanowski L; Bonow RO
    J Am Coll Cardiol; 2021 Sep; 78(10):1068-1077. PubMed ID: 34474740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
    Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial viability in ischemic heart disease: new directions and perspectives.
    Previtali M
    Ital Heart J; 2001 Feb; 2(2):93-9. PubMed ID: 11256549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium.
    Ling LF; Marwick TH; Flores DR; Jaber WA; Brunken RC; Cerqueira MD; Hachamovitch R
    Circ Cardiovasc Imaging; 2013 May; 6(3):363-72. PubMed ID: 23595888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial viability on trial.
    Bolognese L; Reccia MR
    Eur Heart J Suppl; 2024 Apr; 26(Suppl 1):i15-i18. PubMed ID: 38867871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Evolving Paradigm of Revascularization in Ischemic Cardiomyopathy: from Recovery of Systolic Function to Protection Against Future Ischemic Events.
    Isath A; Panza JA
    Curr Cardiol Rep; 2023 Nov; 25(11):1513-1521. PubMed ID: 37874470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of revascularization to improve left ventricular function.
    Patel HC; Ellis SG
    Heart Fail Clin; 2015 Apr; 11(2):203-14. PubMed ID: 25834970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial viability assessment and utility in contemporary management of ischemic cardiomyopathy.
    Katikireddy CK; Samim A
    Clin Cardiol; 2022 Feb; 45(2):152-161. PubMed ID: 35077580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Current Role of Viability Imaging to Guide Revascularization and Therapy Decisions in Patients With Heart Failure and Reduced Left Ventricular Function.
    Kandolin RM; Wiefels CC; Mesquita CT; Chong AY; Boland P; Glineur D; Sun L; Beanlands RS; Mielniczuk LM
    Can J Cardiol; 2019 Aug; 35(8):1015-1029. PubMed ID: 31376903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic utility of myocardial viability assessment.
    Iskander S; Iskandrian AE
    Am J Cardiol; 1999 Mar; 83(5):696-702, A7. PubMed ID: 10080421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myocardial viability in man: state of the art and directions to pursue].
    Vanoverschelde JL
    Bull Mem Acad R Med Belg; 1999; 154(1):91-6; discussion 96-8. PubMed ID: 10535159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is viability still viable after the STICH trial?
    Cortigiani L; Bigi R; Sicari R
    Eur Heart J Cardiovasc Imaging; 2012 Mar; 13(3):219-26. PubMed ID: 22080451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and outcomes of patients with severe left ventricular dysfunction undergoing cardiac MRI viability assessment prior to revascularization.
    Doukas D; Porcaro K; Marot J; Burke L; Joyce C; Weaver F; Nguyen J; Cao JJ; Mathew V; Heroux A; Syed MA
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):675-684. PubMed ID: 33034865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis.
    Bax JJ; Schinkel AF; Boersma E; Elhendy A; Rizzello V; Maat A; Roelandt JR; van der Wall EE; Poldermans D
    Circulation; 2004 Sep; 110(11 Suppl 1):II18-22. PubMed ID: 15364832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF).
    Rezende PC; Hueb W; Bocchi EA; Farkouh M; Junior CVS; Lima EG; Silva EER; Dallan LAO; Gaiotto FA; Garzillo CL; Rochitte CE; Nomura CH; Scudeler TL; Soares PR; Jatene FB; Ramires JAF; Filho RK
    Trials; 2020 Apr; 21(1):337. PubMed ID: 32299458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction.
    Pasquet A; Robert A; D'Hondt AM; Dion R; Melin JA; Vanoverschelde JL
    Circulation; 1999 Jul; 100(2):141-8. PubMed ID: 10402443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of myocardial viability recognized by low dose dipyridamole echocardiography in patients with chronic ischaemic left ventricular dysfunction.
    Sicari R; Ripoli A; Picano E; Borges AC; Varga A; Mathias W; Cortigiani L; Bigi R; Heyman J; Polimeno S; Silvestri O; Gimenez V; Caso P; Severino S; Djordjevic-Dikic A; Ostojic M; Baldi C; Seveso G; Petix N;
    Eur Heart J; 2001 May; 22(10):837-44. PubMed ID: 11409375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of myocardial viability with cardiac magnetic resonance imaging.
    Ozben B; Cinçin AA; Mutlu B
    Anadolu Kardiyol Derg; 2008 Nov; 8 Suppl 2():71-6. PubMed ID: 19028638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.